Notice: Prescription Drug List (PDL): Multiple Additions (2021-10-21)

The purpose of this Notice of Amendment is to notify of the addition of the following medicinal ingredients on the Prescription Drug List (PDL) for human and veterinary use: Infigratinib or its salts, Lurbinectedin or its salts or derivatives, Pemigatinib or its salts, Propylthiouracil or its salts, Sacituzumab govitecan, and Sotorasib.